Myeloma University: the Patient Journey and CAR T-cell Therapy
CAR-T therapy management in multiple myeloma
Description:
A discussion of the patient journey and CAR-T therapy management in multiple myeloma.
Module Objectives:
- Learn about the effectiveness of CAR-T therapy
- Define the patient journey and common processes of CAR-T therapy
- Prepare patients and practitioners for common adverse events of this treatment
Instructor:
Donna Catamero, ANP-BC, OCN, CCRC
Featured
Visit Myeloma University
Created by the International Myeloma Foundation's Nurse Leadership Board, Myeloma University is an educational series for nurses and other healthcare professionals to gain knowledge about multiple myeloma.
Disclaimer:
The information contained in this website does not constitute medical advice, diagnosis or treatment and is for informational purposes only. The information in this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. If you think you may have a medical emergency, call your doctor or 911 immediately.
With support from:
Bristol Myers Squibb, GSK, and Sanofi
